Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Wednesday. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright cut their target price on Aethlon Medical from $23.00 to $10.00 and set a buy rating for the company in a research report on Monday, March 4th.

Aethlon Medical Stock Down 1.1 %

Shares of AEMD stock opened at $1.73 on Wednesday. The business has a 50 day moving average of $1.75 and a two-hundred day moving average of $1.86. Aethlon Medical has a 52 week low of $1.40 and a 52 week high of $7.20. The company has a market cap of $4.53 million, a P/E ratio of -0.35 and a beta of 1.89.

Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($1.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.23) by ($0.14). Analysts expect that Aethlon Medical will post -4.98 EPS for the current fiscal year.

Institutional Trading of Aethlon Medical

Large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Aethlon Medical by 112.9% during the 3rd quarter. Vanguard Group Inc. now owns 1,053,198 shares of the medical equipment provider’s stock valued at $613,000 after acquiring an additional 558,596 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of Aethlon Medical by 11.6% during the 1st quarter. Renaissance Technologies LLC now owns 270,297 shares of the medical equipment provider’s stock valued at $395,000 after acquiring an additional 28,097 shares in the last quarter. Citadel Advisors LLC purchased a new position in shares of Aethlon Medical during the 3rd quarter valued at $72,000. Two Sigma Investments LP grew its holdings in shares of Aethlon Medical by 219.3% during the 1st quarter. Two Sigma Investments LP now owns 127,341 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 87,458 shares in the last quarter. Finally, Jane Street Group LLC grew its holdings in shares of Aethlon Medical by 895.7% during the 4th quarter. Jane Street Group LLC now owns 140,245 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 126,160 shares in the last quarter. 1.99% of the stock is owned by institutional investors and hedge funds.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.